$UTMD
UTAH MEDICAL PRODUCTS INC

2022 Q4 Form 10-Q Financial Statement

#000181188422000015 Filed on November 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $13.58M $12.96M $12.57M
YoY Change 5.12% 3.05% 19.96%
Cost Of Revenue $5.247M $4.769M $4.499M
YoY Change 9.29% 6.0% 13.04%
Gross Profit $8.327M $8.186M $8.073M
YoY Change 2.64% 1.4% 24.2%
Gross Profit Margin 61.34% 63.19% 64.21%
Selling, General & Admin $3.134M $2.933M $2.848M
YoY Change 10.27% 2.98% 2.08%
% of Gross Profit 37.64% 35.83% 35.28%
Research & Development $123.0K $112.0K $127.0K
YoY Change -12.77% -11.81% -2.31%
% of Gross Profit 1.48% 1.37% 1.57%
Depreciation & Amortization $1.738M $1.732M $1.819M
YoY Change -3.55% -4.78% 1.06%
% of Gross Profit 20.87% 21.16% 22.53%
Operating Expenses $3.257M $3.045M $2.975M
YoY Change 9.19% 2.35% 2.23%
Operating Profit $5.070M $5.141M $5.098M
YoY Change -1.17% 0.84% 42.01%
Interest Expense $661.0K
YoY Change 298.19%
% of Operating Profit 13.04%
Other Income/Expense, Net -$140.0K $198.0K $59.00K
YoY Change 21.74% 235.59%
Pretax Income $5.591M $5.339M $5.157M
YoY Change 7.91% 3.53% 43.65%
Income Tax $1.036M $1.059M $951.0K
% Of Pretax Income 18.53% 19.84% 18.44%
Net Earnings $4.555M $4.280M $4.206M
YoY Change 10.24% 1.76% 43.55%
Net Earnings / Revenue 33.55% 33.04% 33.46%
Basic Earnings Per Share $1.18 $1.15
Diluted Earnings Per Share $1.25 $1.18 $1.150M
COMMON SHARES
Basic Shares Outstanding 3.628M shares 3.625M shares 3.647M shares
Diluted Shares Outstanding 3.634M shares 3.658M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.05M $69.51M $64.32M
YoY Change 23.09% 8.07% 38.92%
Cash & Equivalents $75.05M $69.51M $64.32M
Short-Term Investments
Other Short-Term Assets $515.0K $387.0K $373.0K
YoY Change 12.94% 3.75% -6.75%
Inventory $8.814M $8.310M $6.299M
Prepaid Expenses
Receivables $5.538M $6.034M $4.853M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $89.92M $84.24M $75.85M
YoY Change 22.91% 11.07% 32.37%
LONG-TERM ASSETS
Property, Plant & Equipment $10.22M $9.852M $10.93M
YoY Change -3.71% -9.87% -0.63%
Goodwill $13.35M $12.87M
YoY Change -5.28%
Intangibles $10.38M $11.04M
YoY Change -40.06%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $33.96M $34.17M $43.91M
YoY Change -20.06% -22.17% -11.84%
TOTAL ASSETS
Total Short-Term Assets $89.92M $84.24M $75.85M
Total Long-Term Assets $33.96M $34.17M $43.91M
Total Assets $123.9M $118.4M $119.8M
YoY Change 7.12% -1.12% 11.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.218M $1.289M $1.026M
YoY Change 60.05% 25.63% 46.57%
Accrued Expenses $4.742M $4.980M $3.989M
YoY Change 58.91% 24.84% 32.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.960M $6.269M $5.015M
YoY Change 59.15% 25.0% 39.31%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.597M $1.675M $2.539M
YoY Change -4.66% -34.03% 1.56%
Total Long-Term Liabilities $1.597M $1.675M $2.539M
YoY Change -4.66% -34.03% 1.56%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.960M $6.269M $5.015M
Total Long-Term Liabilities $1.597M $1.675M $2.539M
Total Liabilities $9.620M $10.23M $9.772M
YoY Change 13.2% 4.66% 12.32%
SHAREHOLDERS EQUITY
Retained Earnings $126.0M $122.5M
YoY Change 9.27%
Common Stock $287.0K $94.00K
YoY Change -67.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $114.3M $108.2M $110.0M
YoY Change
Total Liabilities & Shareholders Equity $123.9M $118.4M $119.8M
YoY Change 7.12% -1.12% 11.81%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income $4.555M $4.280M $4.206M
YoY Change 10.24% 1.76% 43.55%
Depreciation, Depletion And Amortization $1.738M $1.732M $1.819M
YoY Change -3.55% -4.78% 1.06%
Cash From Operating Activities $5.680M $5.589M $5.991M
YoY Change 13.9% -6.71% 19.58%
INVESTING ACTIVITIES
Capital Expenditures $38.00K -$321.0K -$77.00K
YoY Change -115.02% 316.88% -23.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$38.00K -$321.0K -$77.00K
YoY Change -84.98% 316.88% -23.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $189.0K
YoY Change -154.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -920.0K -1.032M -850.0K
YoY Change -88.6% 21.41% -37.96%
NET CHANGE
Cash From Operating Activities 5.680M 5.589M 5.991M
Cash From Investing Activities -38.00K -321.0K -77.00K
Cash From Financing Activities -920.0K -1.032M -850.0K
Net Change In Cash 4.722M 4.236M 5.064M
YoY Change -241.55% -16.35% 43.05%
FREE CASH FLOW
Cash From Operating Activities $5.680M $5.589M $5.991M
Capital Expenditures $38.00K -$321.0K -$77.00K
Free Cash Flow $5.642M $5.910M $6.068M
YoY Change 7.67% -2.6% 18.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
UT
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-12575
dei Entity Registrant Name
EntityRegistrantName
UTAH MEDICAL PRODUCTS INC
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3745000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0342734
dei Entity Address Address Line1
EntityAddressAddressLine1
7043 South 300 West
dei Entity Address City Or Town
EntityAddressCityOrTown
Midvale
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84047
dei City Area Code
CityAreaCode
801
dei Local Phone Number
LocalPhoneNumber
566-1200
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
UTMD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3627583 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69511000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60974000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6034000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5132000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
8310000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6596000 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
387000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
456000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
84242000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
73158000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9852000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10618000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
406000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
449000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
12871000 usd
CY2021Q4 us-gaap Goodwill
Goodwill
14098000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
50078000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
55865000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
39036000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38552000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11042000 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
17313000 usd
CY2022Q3 us-gaap Assets
Assets
118413000 usd
CY2021Q4 us-gaap Assets
Assets
115636000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1289000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
761000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4980000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2984000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6269000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12955000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12572000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38707000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
36140000 usd
CY2022Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
1479000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
2105000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1675000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1675000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
354000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
396000 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
450000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
577000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10227000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8498000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3625000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3625000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3655000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3655000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
36000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
37000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-14430000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
-9054000 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
58000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
841000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
122522000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
115314000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
108186000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
107138000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118413000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115636000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4769000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4499000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
14838000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13336000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
8186000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
8073000 usd
us-gaap Gross Profit
GrossProfit
23869000 usd
us-gaap Gross Profit
GrossProfit
22804000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2933000 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2848000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8779000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8669000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
112000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
127000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
370000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
385000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
3045000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
2975000 usd
us-gaap Operating Expenses
OperatingExpenses
9149000 usd
us-gaap Operating Expenses
OperatingExpenses
9054000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5141000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
5098000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14720000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
13750000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
198000 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
59000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
348000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5339000 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5157000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15068000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13880000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1059000 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
951000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3150000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3224000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4280000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
4206000 usd
us-gaap Profit Loss
ProfitLoss
11918000 usd
us-gaap Profit Loss
ProfitLoss
10656000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3625000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3647000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3641000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3645000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3634000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3658000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3650000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656000 shares
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2572000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-782000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5377000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-787000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1708000 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3424000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6541000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9869000 usd
us-gaap Profit Loss
ProfitLoss
11918000 usd
us-gaap Profit Loss
ProfitLoss
10656000 usd
us-gaap Depreciation
Depreciation
454000 usd
us-gaap Depreciation
Depreciation
483000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4837000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4996000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
21000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
39000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-409000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-160000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
121000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
123000 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
0 usd
us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
11000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1059000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
802000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2065000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
161000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
540000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
242000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1075000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
811000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
3549000 usd
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
5560000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15467000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
16216000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
771000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
299000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
9000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-780000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-299000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
281000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2495000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
2112000 usd
us-gaap Payments Of Dividends
PaymentsOfDividends
3116000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4564000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2835000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1586000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-351000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8537000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12731000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
60974000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51590000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69511000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64321000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3502000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
3094000 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107471000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20000 usd
CY2022Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
38000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2572000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1051000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4280000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108185000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107138000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
43000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
121000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-2495000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5377000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3162000 usd
us-gaap Profit Loss
ProfitLoss
11918000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
108185000 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
107365000 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
189000 usd
CY2021Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
41000 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-782000 usd
CY2021Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1040000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
4206000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109980000 usd
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
102822000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
281000 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
123000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-787000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3116000 usd
us-gaap Profit Loss
ProfitLoss
10656000 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
109980000 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1699000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1468000 usd
CY2022Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1275000 usd
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1398000 usd
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
5336000 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
3730000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
8310000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
6596000 usd
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38000 usd
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
121000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
123000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
0 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12955000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38707000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
4280000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
4206000 usd
us-gaap Profit Loss
ProfitLoss
11918000 usd
us-gaap Profit Loss
ProfitLoss
10656000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3625000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3647000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3641000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3645000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9000 shares
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
9000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
11000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3634000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3658000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3650000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3656000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.18
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.92
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.91

Files In Submission

Name View Source Status
0001811884-22-000015-index-headers.html Edgar Link pending
0001811884-22-000015-index.html Edgar Link pending
0001811884-22-000015.txt Edgar Link pending
0001811884-22-000015-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
utmd-20220930.htm Edgar Link pending
utmd-20220930.xsd Edgar Link pending
utmd_ex31z1.htm Edgar Link pending
utmd_ex31z2.htm Edgar Link pending
utmd_ex32z1.htm Edgar Link pending
utmd_ex32z2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
utmd-20220930_cal.xml Edgar Link unprocessable
utmd-20220930_def.xml Edgar Link unprocessable
utmd-20220930_pre.xml Edgar Link unprocessable
utmd-20220930_lab.xml Edgar Link unprocessable
utmd-20220930_htm.xml Edgar Link completed